AK

Achaogen

- NASDAQ:AKAO
Last Updated 2019-08-23

LinkedIn Profile

Access Achaogen historical Linkedin company profile data on number of followers, employee headcount and more

Records

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
nasdaq:akao 57863 Aug 23rd, 2019 12:00AM Achaogen 5.9K 107.00 Open Biotechnology Aug 22nd, 2019 10:05PM Aug 22nd, 2019 10:05PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 Aug 22nd, 2019 12:00AM Achaogen 5.9K 107.00 Open Biotechnology Aug 22nd, 2019 12:23PM Aug 22nd, 2019 12:23PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 Aug 21st, 2019 12:00AM Achaogen 5.9K 107.00 Open Biotechnology Aug 21st, 2019 11:48AM Aug 21st, 2019 11:48AM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 Aug 20th, 2019 12:00AM Achaogen 5.9K 107.00 Open Biotechnology Aug 20th, 2019 01:01PM Aug 20th, 2019 01:01PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 Aug 19th, 2019 12:00AM Achaogen 5.9K 107.00 Open Biotechnology Aug 18th, 2019 10:06PM Aug 18th, 2019 10:06PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 Aug 18th, 2019 12:00AM Achaogen 5.9K 107.00 Open Biotechnology Aug 17th, 2019 10:06PM Aug 17th, 2019 10:06PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 Aug 17th, 2019 12:00AM Achaogen 5.9K 107.00 Open Biotechnology Aug 16th, 2019 10:06PM Aug 16th, 2019 10:06PM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 Aug 16th, 2019 12:00AM Achaogen 5.9K 107.00 Open Biotechnology Aug 16th, 2019 10:45AM Aug 16th, 2019 10:45AM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 Aug 15th, 2019 12:00AM Achaogen 5.9K 107.00 Open Biotechnology Aug 15th, 2019 11:41AM Aug 15th, 2019 11:41AM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology
nasdaq:akao 57863 Aug 14th, 2019 12:00AM Achaogen 5.9K 107.00 Open Biotechnology Aug 14th, 2019 11:34AM Aug 14th, 2019 11:34AM Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients. Open Open 1 Tower Place, Suite 300 South San Francisco CA US 94080 Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.